Who was the client?
Diagnostic Medical Systems (DMS) is a French company active in the medical imaging industry with a presence on all continents through a network of national distributors, subsidiaries and joint ventures. The company is listed on the Euronext Growth market in Paris (ALDMS).
What was the client’s challenge?
DMS wanted to conduct a reverse takeover of Asit Biotech, a listed company on the Euronext stock markets of Brussels and Paris, while the target was in the process of a judicial reorganisation.
What solution did we come up with for the client?
Steven De Schrijver and his team assisted DMS in preparing for the reverse takeover. As part of this transaction, Asit Biotech SA changed its name to DMS Imaging SA. This transaction is part of the DMS Group strategy to make DMS Imaging an independent European medical imaging group, a player in market consolidation and a leading partner of the largest international medtechs.
Agio Legal also assisted in drafting the prospectus and listing the shares on Euronext Brussels and Paris. The shares were finally listed on the Euronext stock market in December 2022.
